Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TENNCARE PRIOR AUTHORIZATION APPROVED FOR 80% OF PHYSICIANS

Executive Summary

TENNCARE PRIOR AUTHORIZATION APPROVED FOR 80% OF PHYSICIANS who reported having sought prior approval for a drug not included on the TermCare formulary, according to a Pfizer-supported phone survey of 200 TermCare doctors. The survey was commissioned by the Andrew Jackson Institute, which describes itself as a "nonpartisan public policy think tank focused on Tennessee state issues," and conducted by Yankelovich Partners. "Funding was provided by Pfizer," the institute reported.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel